# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Scotiabank analyst Sung Nam maintains Quanterix (NASDAQ:QTRX) with a Sector Outperform and lowers the price target from $32 ...
TD Cowen analyst Daniel Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $17 to $15.
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by ...
Quanterix improves on its best-in-class p-Tau 217 standalone test with new multi-marker approach reducing the number of patient...
Goldman Sachs analyst Matthew Sykes maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $35 to $24.
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.33) by ...
Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $32 to $25.